Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21

J Immunol. 2008 Apr 15;180(8):5393-401. doi: 10.4049/jimmunol.180.8.5393.

Abstract

The activity of regulatory T cells (Treg) is widely accepted to play a central role in preventing pathogenic immune responses against self-Ags. However, it is not clear why such regulation breaks down during the onset of autoimmunity. We have studied self-Ag-specific Treg during the induction of spontaneous diabetes. Our data reveal a shift in the balance between regulatory and pathogenic islet-reactive T cells in the pancreas-draining lymph nodes during disease onset. Treg function was not compromised during disease initiation, but instead conventional T cells showed reduced susceptibility to Treg-mediated suppression. Release from Treg suppression was associated with elevated levels of IL-21 in vivo, and provision of this cytokine abrogated Treg suppression in vitro and in vivo. These data suggest that immunological protection of a peripheral tissue by Treg can be subverted by IL-21, suggesting new strategies for intervention in autoimmunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer
  • Animals
  • Autoimmunity*
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 1 / immunology*
  • Disease Progression
  • Immune Tolerance
  • Interleukins / immunology
  • Interleukins / metabolism*
  • Lymph Nodes / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Mutant Strains
  • Mice, Transgenic
  • Ovalbumin / immunology
  • Pancreas / immunology
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism

Substances

  • Blood Glucose
  • Interleukins
  • Ovalbumin
  • interleukin-21